6 |
5 |
14
I have no clue why all the looksmaxxers glaze Semax (well, it’s for money), it’s terrible, but oh! It’s a peptide!
Semax’s effects are mild and inconsistent. It's a subtle mood lift or slight focus benefit at best. Second, Semax has poor pharmacokinetics. It’s a short peptide with limited brain exposure and a very brief window of action. Many modern compounds are specifically designed to cross the blood–brain barrier efficiently and maintain stable engagement.
Third, Semax relies heavily on indirect mechanisms (vague BDNF signaling and melanocortin activity). That sounds impressive, but in practice it’s unfocused. Newer research nootropics target specific receptors with far more predictable cognitive outcomes.
Compare this to compounds like TAK-653, BPN-14770, or ACD-856, which were engineered for sustained cognitive enhancement with repeat dosing. Semax is outdated science. It comes from an era when “neurotrophic” effects were exciting on paper but poorly optimized.
I'm all for supporting Russia, but the Soviet biopeptide regulator era is over. Also a shoutout to Vladimir Khavinso for paving the way with other Russian peptides but none of his stuff got approved here in the US.
bro....but you dont understand bro...PIG BRAIN BRO DOESNT THAT MEAN THAT...BRO WHAT ABOUT MY FOCUS BRO
what do you mean semax doesn’t work, i used it last summer and now i beat all my friend at chess. while you are playin the natty game im boosting my iq by 15 points🤣🤣
Try using 2-3mg TAK-653 + 7.5-12.5mg BPN14770 while playing chess
For many first-time nootropic users, Semax feels effective because it's new. Without a baseline for comparison, slight mood shifts or placebo gets interpreted as major cognitive enhancement. Semax became better marketed, not actually better. It's the result of marketing and commissions. When creators earn a percentage of each sale, such as when you use their code in check out, there's a built-in incentive to frame a compound as "life-changing." This happens even when they know results are actually subtle, inconsistent, and condition-dependent. Semax relies on nasal absorption to reach the CNS, strict storage, and precise timing (in the morning) to produce effects that are often mild at best. Buzzwords like BDNF, neurotrophic peptides, and Russian research make it sound more advanced than it actually is.
Peptides are pretty mid for cognition in general unless they are super-selective to a specific pathway. Even if they are they typically have poor pharmacokinetics like a short half life, poor BBB penetration, and poor stability meaning they can't be used orally so they must be used with injection or intranasal ROA. With peptides you can't design the specific structure to dock in a specific site, as it is simply a conjugation of amino acids. Most peptides are developed from larger fragments or proteins instead of designed from the ground up to dock with a site. For that reason it's hard to make allosteric peptides or selective ones.
There are modifications you can do to peptide structures to improve these downsides but it's a complexity that makes development much harder so finding modified peptides is pretty rare. Small molecules are better for neurology really, though for some esoteric pathways the only ligands are peptides so you have to make do.
